Meisi Lin
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
Papers in
-
- Infant Nutrition and Health 3
- Microbial Metabolites in Food Biotechnology 1
- Genetics 4
- Inflammatory Bowel Disease 4
- Co-authors
- Fei Gao (8 shared papers)Ruifeng Luo (7 shared papers)Qiyan Chen (6 shared papers)Jinming Zhang (5 shared papers)Chen Zhang (3 shared papers)Xiulan Pu (4 shared papers)Haiting Xu (4 shared papers)Jinfeng Shi (3 shared papers)
In The Last Decade
Meisi Lin
14 papers receiving 426 citations
Peers
Comparison fields: 5 of 76
- Pharmaceutical Science 95
- Molecular Medicine 45
- Biomaterials 79
- Nutrition and Dietetics 61
- Genetics 104
Countries citing papers authored by Meisi Lin
This map shows the geographic impact of Meisi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meisi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meisi Lin more than expected).
Fields of papers citing papers by Meisi Lin
This network shows the impact of papers produced by Meisi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meisi Lin. The network helps show where Meisi Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Meisi Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 115 | |
| 2 | 2020 | 92 | |
| 3 | 2021 | 58 | |
| 4 | 2023 | 52 | |
| 5 | 2021 | 51 | |
| 6 | 2021 | 31 | |
| 7 | 2022 | 10 | |
| 8 | 2021 | 6 | |
| 9 | 2020 | 3 | |
| 10 | 2020 | 3 | |
| 11 | 2022 | 2 | |
| 12 | 2022 | 2 | |
| 13 | 2020 | 2 | |
| 14 | 2022 | 2 |
About Meisi Lin
Meisi Lin is a scholar working on Nutrition and Dietetics, Genetics, Molecular Biology, Marketing and Molecular Medicine, having authored 14 papers that have together received 429 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (4 papers), Infant Nutrition and Health (3 papers), Gut microbiota and health (2 papers), Curcumin's Biomedical Applications (2 papers), Customer churn and segmentation (2 papers), Pharmacological Effects of Natural Compounds (1 paper), Microbial Metabolites in Food Biotechnology (1 paper) and Berberine and alkaloids research (1 paper). The work is most often cited by research in Pharmaceutical Science (95 citations), Molecular Medicine (45 citations), Biomaterials (79 citations), Nutrition and Dietetics (61 citations) and Genetics (104 citations). Meisi Lin has collaborated with scholars based in China, Macao and Hong Kong. Frequent co-authors include Fei Gao, Ruifeng Luo, Qiyan Chen, Jinming Zhang, Chen Zhang, Xiulan Pu, Haiting Xu, Jinfeng Shi, Naijing Ye and Shanshan Qi. Their work appears in journals such as Carbohydrate Polymers, International Journal of Embedded Systems, Frontiers in Bioengineering and Biotechnology, Medicine and Journal of Nanobiotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.